Ribonucleic acid (
RNA) aptamers with high affinity and specificity for
cancer-specific
cell-surface antigens are promising
reagents for targeted molecular imaging of
cancer using positron emission tomography (PET). For this application, aptamers must be conjugated to
chelators capable of coordinating PET-
radionuclides (e.g.,
copper-64, (64)Cu) to enable radiolabeling for in vivo imaging of
tumors. This study investigates the choice of
chelator and radiolabeling parameters such as pH and temperature for the development of (64)Cu-labeled
RNA-based targeted agents for PET imaging. The characterization and optimization of labeling conditions are described for four
chelator-aptamer complexes. Three commercially available bifunctional macrocyclic
chelators (1,4,7,10-tetraazacyclododecane-1,4,7-triacetic
acid mono
N-hydroxysuccinimide [
DOTA-NHS]; S-2-(4-isothiocyanatobenzyl)-1,4,7-
triazacyclononane-1,4,7-triacetic
acid [p-SCN-Bn-
NOTA]; and p-SCN-Bn-3,6,9,15-tetraazabicyclo [9.3.1]pentadeca-1(15),11,13-triene-3,6,9-triacetic
acid [p-SCN-Bn-PCTA]), as well as the polyamino-macrocyclic
diAmSar (3,6,10,13,16,19-hexaazabicyclo[6.6.6] icosane-1,8-
diamine) were conjugated to A10-3.2, a
RNA aptamer which has been shown to bind specifically to a
prostate cancer-specific
cell-surface antigen (PSMA). Although a commercial bifunctional version of
diAmSar was not available,
RNA conjugation with this
chelator was achieved in a two-step reaction by the addition of a
disuccinimidyl suberate linker. Radiolabeling parameters (e.g., pH, temperature, and time) for each
chelator-
RNA conjugate were assessed in order to optimize specific activity and RNA stability. Furthermore, the radiolabeled
chelator-coupled
RNA aptamers were evaluated for binding specificity to their target
antigen. In summary, key parameters were established for optimal radiolabeling of
RNA aptamers for eventual PET imaging with (64)Cu.